All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for INDIVIOR INC. · pharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income · posted Jul 20, 2025

Official filing document

Bills named in this filing 2

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 2

Pharmacy

Issues related to overdose reversal products including Naloxone; H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4); FY2026 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; FY2026 Commerce, Justice, Science, and Related Agencies Appropriations.

Medicare/Medicaid

Medicaid policies related to substance use disorder; H.R.1, One Big Beautiful Bill Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.